18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
for a Three-Year Term Expiring at the 2026 Annual Meeting
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence Of The Board … Of The Board Of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Stockholder Communications With The Board
8-K
EX-99.1
h2kxw9 p9n
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
agueaod4b9wuvr7su2fs
27 Apr 22
Definitive proxy
5:03pm
10-K
shuphg2n7aj471
28 Mar 22
Annual report
4:51pm
10-K
EX-10.3
vrxp61ivm lzsv
28 Mar 22
Annual report
4:51pm
10-Q
8jwdt 5gfibgrz3
16 Aug 21
Quarterly report
4:51pm
424B4
wwsyq
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
3btb3
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
5efhqp ilr
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.3
gwrh1ezo2vyik
24 Jun 21
IPO registration (amended)
8:17am
S-1
8cogbg 1yqvq
9 Jun 21
IPO registration
5:02pm
DRS/A
p8py t1t7tlp
14 May 21
Draft registration statement (amended)
12:00am
DRS
324easg p8rr105e
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next